Cargando…

XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy

Detalles Bibliográficos
Autores principales:	Li, Xuanzong, Zou, Bing, Wang, Shijiang, Wang, Linlin, Yu, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502403/ https://www.ncbi.nlm.nih.gov/pubmed/34627293 http://dx.doi.org/10.1186/s12967-021-03098-5

Ejemplares similares

The negative relationship between patients with NSCLC harbored STK11/KEAP1 copy number variation and immune microenvironment infiltration
por: Zhang, Chenyue
Publicado: (2021)

Construction of a B cell-related gene pairs signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer
por: Li, Xuanzong, et al.
Publicado: (2022)

Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
por: Wohlhieter, Corrin A., et al.
Publicado: (2020)

STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
por: Papillon-Cavanagh, Simon, et al.
Publicado: (2020)

Correction: STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
Publicado: (2020)

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
por: Shire, Norah J., et al.
Publicado: (2020)

Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report
por: Fricke, Jeremy, et al.
Publicado: (2020)

AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1(+) CD8 T cells
por: Li, Huiyu, et al.
Publicado: (2022)

Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma
por: Li, Xuanzong, et al.
Publicado: (2021)

Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer
por: Sumii, Masahiko, et al.
Publicado: (2023)

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation
por: Nie, Wei, et al.
Publicado: (2021)

STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation
por: Granado-Martínez, Paula, et al.
Publicado: (2020)

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer
por: Kim, Nayoung, et al.
Publicado: (2016)

Overexpression and Selective Anticancer Efficacy of ENO3 in STK11 Mutant Lung Cancers
por: Park, Choa, et al.
Publicado: (2019)

Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway
por: Xia, Yang, et al.
Publicado: (2022)

Antitumor efficacy of XPO1 inhibitor Selinexor in KRAS-mutant lung adenocarcinoma patient-derived xenografts
por: Rosen, Joshua C., et al.
Publicado: (2021)

Unraveling the Deleterious Effects of Cancer-Driven STK11 Mutants Through Conformational Sampling Approach
por: Lopus, Merlin, et al.
Publicado: (2016)

XPO1, therapeutic … and prognostic target in sarcomas
por: Bertucci, François, et al.
Publicado: (2016)

Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation
por: An, Josiah, et al.
Publicado: (2021)

Hope and Challenges: Immunotherapy in EGFR-Mutant NSCLC Patients
por: Yan, Dan
Publicado: (2023)

Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis
por: Guo, Meiying, et al.
Publicado: (2019)

Quantitative phosphoproteomic analyses identify STK11IP as a lysosome-specific substrate of mTORC1 that regulates lysosomal acidification
por: Zi, Zhenzhen, et al.
Publicado: (2022)

Tumor loss-of-function mutations in STK11/LKB1 induce cachexia
por: Iyengar, Puneeth, et al.
Publicado: (2023)

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
por: Julian, Cristina, et al.
Publicado: (2023)

Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
por: Nakayama, Robert, et al.
Publicado: (2016)

Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING Ubiquitination
por: Wang, Zhiguo, et al.
Publicado: (2022)

Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation
por: Gong, Meiling, et al.
Publicado: (2020)

Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer
por: Zhao, Qian, et al.
Publicado: (2021)

Primary Resistance to Immune Checkpoint Blockade in an STK11/TP53/KRAS-Mutant Lung Adenocarcinoma with High PD-L1 Expression
por: Kwack, Won Gun, et al.
Publicado: (2020)

Peutz-Jeghers syndrome with germline mutation of STK11
por: Chae, Hyun-Dong, et al.
Publicado: (2014)

Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling
por: Long, Huideng, et al.
Publicado: (2023)

Identification of Stk25 as a Genetic Modifier of Tau Phosphorylation in Dab1-Mutant Mice
por: Matsuki, Tohru, et al.
Publicado: (2012)

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53
por: Deng, Manman, et al.
Publicado: (2020)

The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
por: Mograbi, Baharia, et al.
Publicado: (2021)

Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
por: Sumbly, Vikram, et al.
Publicado: (2022)

Protein biomarkers for response to XPO1 inhibition in haematologic malignancies
por: Totiger, Tulasigeri M., et al.
Publicado: (2023)

Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis
por: Zhao, Lei, et al.
Publicado: (2021)

Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
por: Sexton, Rachel, et al.
Publicado: (2019)

Mutations in STK11 gene in Czech Peutz-Jeghers patients
por: Vasovčák, Peter, et al.
Publicado: (2009)

Mutational Analysis of STK11 h Gene in Ovarian Carcinomas
por: Nishioka, Yoshihiro, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_fhm3kpklnlptdtpssvk9lp17gj